Norway Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook
Norway viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
Norway viral vector and plasmid dna manufacturing market highlights
- The Norway viral vector and plasmid dna manufacturing market generated a revenue of USD 29.2 million in 2023 and is expected to reach USD 96.2 million by 2030.
- The Norway market is expected to grow at a CAGR of 18.6% from 2024 to 2030.
- In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
- Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
Viral vector and plasmid dna manufacturing market data book summary
| Market revenue in 2023 | USD 29.2 million |
| Market revenue in 2030 | USD 96.2 million |
| Growth rate | 18.6% (CAGR from 2023 to 2030) |
| Largest segment | Adeno-associated virus (aav) |
| Fastest growing segment | Adeno-associated virus (AAV) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
| Key market players worldwide | Merck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 0.5% of the global viral vector and plasmid dna manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany viral vector and plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 951.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vector And Plasmid DNA Manufacturing Market Scope
Viral Vector And Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway viral vector and plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 20.55% in 2023. Horizon Databook has segmented the Norway viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
Norway’s Viral vectors and plasmid DNA manufacturing market is highly competitive due to the presence of established and mid-tier companies, as well as startups.
Various growth strategies adopted by these corporations, such as strategic alliances and collaborations with biopharmaceutical & pharmaceutical companies, are propelling market growth.
For instance, in December 2022 Nykode Therapeutics ASA and Richter-Helm BioLogics GmbH & Co KG announced a partnership to supply pDNA for NyKode’s vaccines portfolio.
Reasons to subscribe to Norway viral vector and plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway viral vector and plasmid dna manufacturing market databook
-
Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)
Norway Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
